Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tuberculous Meningitis during Chemotherapy for Advanced Gastric Cancer.
Matsumoto H, Sasaki A, Nakamura Y, Kawazoe A, Kuboki Y, Okinaka K, Shitara K. Matsumoto H, et al. Among authors: sasaki a. Case Rep Oncol. 2018 Apr 5;11(1):228-233. doi: 10.1159/000488313. eCollection 2018 Jan-Apr. Case Rep Oncol. 2018. PMID: 29805373 Free PMC article.
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.
Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara K, Sakaguchi S, Nishikawa H. Kamada T, et al. Among authors: sasaki a. Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008. doi: 10.1073/pnas.1822001116. Epub 2019 Apr 26. Proc Natl Acad Sci U S A. 2019. PMID: 31028147 Free PMC article.
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer.
Sasaki A, Nakamura Y, Togashi Y, Kuno H, Hojo H, Kageyama S, Nakamura N, Takashima K, Kadota T, Yoda Y, Mishima S, Sawada K, Kotani D, Kawazoe A, Kuboki Y, Taniguchi H, Kojima T, Doi T, Yoshino T, Yano T, Kobayashi T, Akimoto T, Nishikawa H, Shitara K. Sasaki A, et al. Gastric Cancer. 2020 Sep;23(5):893-903. doi: 10.1007/s10120-020-01058-4. Epub 2020 Mar 16. Gastric Cancer. 2020. PMID: 32180056
Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer.
Ishii T, Kawazoe A, Sasaki A, Mishima S, Kentaro S, Nakamura Y, Kotani D, Kuboki Y, Taniguchi H, Kojima T, Doi T, Yoshino T, Kuwata T, Ishii G, Shitara K. Ishii T, et al. Among authors: sasaki a. Ther Adv Med Oncol. 2020 Jul 17;12:1758835920942377. doi: 10.1177/1758835920942377. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32733607 Free PMC article.
Emergence of Concurrent Multiple EGFR Mutations and MET Amplification in a Patient With EGFR-Amplified Advanced Gastric Cancer Treated With Cetuximab.
Nakamura Y, Sasaki A, Yukami H, Jogo T, Kawazoe A, Kuboki Y, Taniguchi H, Yamashita R, Kuwata T, Ozawa M, Nakamura M, Yoshino T, Shitara K. Nakamura Y, et al. Among authors: sasaki a. JCO Precis Oncol. 2020 Nov 17;4:PO.20.00263. doi: 10.1200/PO.20.00263. eCollection 2020. JCO Precis Oncol. 2020. PMID: 33283138 Free PMC article. No abstract available.
2,474 results